Shu Feng Zhang

Presidente presso Beijing Biostar Pharmaceuticals Co. Ltd.

55 anni

Consumer Services

Health Technology

Profilo

Shu Feng Zhang is currently the Chairman-Supervisory Board at Beijing Biostar Pharmaceuticals Co. Ltd.
He started this position in 2021.
Prior to his current role, he obtained an MBA from Tsinghua University in 1999.

Posizioni attive di Shu Feng Zhang

Società	Posizione	Inizio
Beijing Biostar Pharmaceuticals Co. Ltd. Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China.	Presidente	01/03/2021

Tutte le posizioni attive di Shu Feng Zhang

Formazione di Shu Feng Zhang

Tsinghua University

Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Shu Feng Zhang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Beijing Biostar Pharmaceuticals Co. Ltd. Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China.	Health Technology